DEUTSCHE BANK AG\
BankPosition in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ARWR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,164,550
-$4,135,128 QoQ
Shares Held
149,240
-42.6% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ARWR ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,164,550 | 149,240 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $16,299,678 | 259,963 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $16,071,292 | 242,074 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $8,487,022 | 246,072 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,720,045 | 235,446 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,184,858 | 249,989 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,868,521 | 258,964 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $4,286,153 | 221,278 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $5,858,274 | 225,405 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $6,648,097 | 232,451 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $7,410,737 | 242,181 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,989,026 | 222,889 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $7,754,016 | 217,443 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,208,800 | 244,441 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,194,545 | 226,690 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,321,234 | 221,520 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,774,997 | 334,422 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $15,718,966 | 341,791 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,153,926 | 243,649 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $15,289,979 | 244,914 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $22,061,506 | 266,379 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $28,488,960 | 429,633 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $23,640,971 | 308,106 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,525,765 | 174,774 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,472,579 | 196,170 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,133,926 | 74,172 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||